Adicet Bio
NASDAQ: ACETMenlo Park, US · Founded 2014 · Delaware corporation · 6 known investors
Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer. The company works on off-the-shelf immune cell therapies based on gamma delta 1 CAR T cell technology.
Founders & leadership
Adicet Bio was founded in 2014 by Aya Jakobovits.
AJ
Aya JakobovitsFounder
NH
Nathan HubbardExecutive
Board
JS
CG
FG
Florent GrosBoard director
EC
Investors · 6
Reported raises · per SEC filings
Form D private placements$116.8M disclosed across 3 rounds · 2015–2019
▶$80MraisedOct 2019 · 18 investors · BiotechnologyRule 506(b)
▶$80MraisedOct 2019 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Erez ChimovitsDirector
- Francesco GaliniExecutive Officer
- Carrie KrehlikExecutive Officer
- Stewart AbbotExecutive Officer
- Carl GordonDirector
- Michal SilverbergDirector
- Donald SantelExecutive Officer, Director
- Yair SchindelDirector
- Asish XavierDirector
- Aya JakobovitsDirector
- Offering amount
- $80M
- Amount sold
- $80M
- Sales commissions
- $2.5M
- Placement agents
- Beech Hill Securities, Inc., Beech Hill Securities, Inc., Beech Hill Securities, Inc.
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$25.4MraisedOct 2018 · 5 investors · BiotechnologyRule 506(b)
▶$25.4MraisedOct 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SilversteinDirector
- Aya JakobovitsDirector
- Donald SantelExecutive Officer, Director
- Brian HoganExecutive Officer
- Carl GordonDirector
- Carrie KrehlikExecutive Officer
- Anne AltmeyerExecutive Officer
- Florent GrosDirector
- Erez ChimovitsDirector
- Steward AbbotExecutive Officer
- Offering amount
- $43.3M
- Amount sold
- $25.4M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$11.3MraisedJan 2016 · 6 investors · BiotechnologyRule 506(b)
▶$11.3MraisedJan 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nathan HubbardExecutive Officer
- Aya JakobovitsExecutive Officer, Director
- Jonathan SilversteinDirector
- Carl GordonDirector
- Florent GrosDirector
- Erez ChimovitsDirector
- Offering amount
- $13.9M
- Amount sold
- $11.3M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
TradingView15 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Public15 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TipRanks15 shared keywordsFinancial analysis and stock research platform.
Robinhood14 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Simply Wall St14 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
StockTwits14 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Seeking Alpha14 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Adicet Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adicet Bio do?
- Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer. The company works on off-the-shelf immune cell therapies based on gamma delta 1 CAR T cell technology.
- Who founded Adicet Bio?
- Adicet Bio was founded by Aya Jakobovits in 2014.
- Who are Adicet Bio's investors?
- Adicet Bio's investors include Foresite Capital, OrbiMed, Pontifax Venture Capital, Quan Capital, aMoon, Novartis Venture Fund.
- How much funding has Adicet Bio raised?
- Adicet Bio has disclosed $116.8M raised across 3 rounds.
- Where is Adicet Bio headquartered?
- Adicet Bio is headquartered in Menlo Park, US.